loadpatents
Patent applications and USPTO patent grants for Li; Dansu.The latest application filed is for "combination therapies with ire1 small molecule inhibitors".
Patent | Date |
---|---|
Combination Therapies With Ire1 Small Molecule Inhibitors App 20220265656 - Vacca; Joseph P. ;   et al. | 2022-08-25 |
Ire1 Small Molecule Inhibitors App 20220251065 - Vacca; Joseph P. ;   et al. | 2022-08-11 |
Treatment Of Fibrosis With Ire1 Small Molecule Inhibitors App 20220227730 - Vacca; Joseph P. ;   et al. | 2022-07-21 |
Pyrazole Compounds And Uses Thereof App 20220017493 - Li; Dansu ;   et al. | 2022-01-20 |
Ire1 Small Molecule Inhibitors App 20210284628 - Vacca; Joseph P. ;   et al. | 2021-09-16 |
Pyrazole Pyrimidine Derivative And Uses Thereof App 20210251992 - Ben-Neriah; Yinon ;   et al. | 2021-08-19 |
Pyrazole compounds and uses thereof Grant 11,072,599 - Li , et al. July 27, 2 | 2021-07-27 |
IRE1 small molecule inhibitors Grant 11,021,466 - Vacca , et al. June 1, 2 | 2021-06-01 |
Pyrazole pyrimidine derivative and uses thereof Grant 10,960,003 - Ben Neriah , et al. March 30, 2 | 2021-03-30 |
IRE1 small molecule inhibitors Grant 10,961,218 - Vacca , et al. March 30, 2 | 2021-03-30 |
Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20210061803 - Ciblat; Stephane ;   et al. | 2021-03-04 |
IRE1 small molecule inhibitors Grant 10,934,275 - Vacca , et al. March 2, 2 | 2021-03-02 |
IRE1 Small Molecule Inhibitors App 20200392106 - Vacca; Joseph P. ;   et al. | 2020-12-17 |
Inhibitors of cyclin-dependent kinase 7 (CDK7) Grant 10,865,206 - Ciblat , et al. December 15, 2 | 2020-12-15 |
Pyrazole Pyrimidine Derivative And Uses Thereof App 20200354340 - Li; Dansu ;   et al. | 2020-11-12 |
IRE1 small molecule inhibitors Grant 10,745,379 - Vacca , et al. A | 2020-08-18 |
IRE1 Small Molecule Inhibitors App 20200157079 - Vacca; Joseph P. ;   et al. | 2020-05-21 |
Inhibitors of cyclin-dependent kinase 7 (CDK7) Grant 10,519,135 - Sprott , et al. Dec | 2019-12-31 |
Pyrazole Pyrimidine Derivative And Uses Thereof App 20190365759 - Ben Neriah; Yinon ;   et al. | 2019-12-05 |
Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20190337940 - Ciblat; Stephane ;   et al. | 2019-11-07 |
IRE1 Small Molecule Inhibitors App 20190276434 - Vacca; Joseph P. ;   et al. | 2019-09-12 |
IRE1 small molecule inhibitors Grant 10,392,367 - Vacca , et al. A | 2019-08-27 |
Pyrazole pyrimidine derivative and uses thereof Grant 10,376,511 - Ben Neriah , et al. A | 2019-08-13 |
Ire1 Small Molecule Inhibitors App 20190169160 - VACCA; Joseph P. ;   et al. | 2019-06-06 |
Inhibitors of cyclin-dependent kinase 7 (CDK7) Grant 10,308,648 - Ciblat , et al. | 2019-06-04 |
Ire1 Small Molecule Inhibitors App 20180346446 - VACCA; Joseph P. ;   et al. | 2018-12-06 |
Ire1 Small Molecule Inhibitors App 20180346447 - Vacca; Joseph P. ;   et al. | 2018-12-06 |
Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20180319772 - Sprott; Kevin ;   et al. | 2018-11-08 |
Inhibitors of cyclin-dependent kinase 7 (CDK7) Grant 10,106,526 - Sprott , et al. October 23, 2 | 2018-10-23 |
Inhibitors of cyclin-dependent kinase 7 (CDK7) Grant 10,059,690 - Ciblat , et al. August 28, 2 | 2018-08-28 |
Pyrazole Pyrimidine Derivative And Uses Thereof App 20180214447 - Ben Neriah; Yinon ;   et al. | 2018-08-02 |
Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20180208578 - Ciblat; Stephane ;   et al. | 2018-07-26 |
Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20170327496 - Ciblat; Stephane ;   et al. | 2017-11-16 |
Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20170183355 - Sprott; Kevin ;   et al. | 2017-06-29 |
Multivalent Ras Binding Compounds App 20170158702 - VACCA; Joseph P. ;   et al. | 2017-06-08 |
Benzoxazolinone compounds with selective activity in voltage-gated sodium channels Grant 9,624,208 - Pero , et al. April 18, 2 | 2017-04-18 |
Bicycloamine-substituted-N-benzenesulfonamide compounds with selective activity in voltage-gated sodium channels Grant 9,586,968 - Layton , et al. March 7, 2 | 2017-03-07 |
Bicycloamine-substituted-n-benzenesulfonamide Compounds With Selective Activity In Voltage-gated Sodium Channels App 20170002008 - Layton; Mark E. ;   et al. | 2017-01-05 |
Benzoxazolinone compounds with selective activity in voltage-gated sodium channels Grant 9,273,040 - Layton , et al. March 1, 2 | 2016-03-01 |
Isoxazolopyridine orexin receptor antagonists Grant 9,242,995 - Li , et al. January 26, 2 | 2016-01-26 |
Benzoxazolinone Compounds With Selective Activity In Voltage-gated Sodium Channels App 20150252034 - Pero; Joseph E. ;   et al. | 2015-09-10 |
Isoxazolopyridine Orexin Receptor Antagonists App 20150038502 - Li; Dansu ;   et al. | 2015-02-05 |
Compounds for the treatment of inflammatory disorders Grant 8,859,529 - Shankar , et al. October 14, 2 | 2014-10-14 |
Benzoxazolinone Compounds With Selective Activity In Voltage-gated Sodium Channels App 20140303143 - Layton; Mark E. ;   et al. | 2014-10-09 |
Compounds for the treatment of inflammatory disorders Grant 8,569,336 - Tong , et al. October 29, 2 | 2013-10-29 |
Compounds for the treatment of inflammatory disorders Grant 8,541,572 - Kozlowski , et al. September 24, 2 | 2013-09-24 |
Compounds for the treatment of inflammatory diseases Grant 8,450,355 - Wong , et al. May 28, 2 | 2013-05-28 |
Compounds for the treatment of inflammatory disorders Grant 8,178,553 - Lavey , et al. May 15, 2 | 2012-05-15 |
Compounds For The Treatment Of Inflammatory Disorders App 20120015926 - Tong; Ling ;   et al. | 2012-01-19 |
Compounds For The Treatment Of Inflammatory Disorders App 20120010181 - Kozlowski; Joseph A. ;   et al. | 2012-01-12 |
Compounds For The Treatment Of Inflammatory Diseases App 20110288077 - Wong; Michael K.C. ;   et al. | 2011-11-24 |
Compounds For The Treatment Of Inflammatory Disorders App 20110288054 - Shankar; Bandarpalle B. ;   et al. | 2011-11-24 |
Compounds for the treatment of inflammatory disorders Grant 7,879,890 - Yu , et al. February 1, 2 | 2011-02-01 |
Compounds for the treatment of inflammatory disorders Grant 7,772,263 - Lavey , et al. August 10, 2 | 2010-08-10 |
Compounds For The Treatment Of Inflammatory Disorders App 20100145048 - Guo; Zhuyan ;   et al. | 2010-06-10 |
Compounds For The Treatment Of Inflammatory Disorders App 20100120838 - Lavey; Brian J. ;   et al. | 2010-05-13 |
Compounds for the treatment of inflammatory disorders Grant 7,687,527 - Yu , et al. March 30, 2 | 2010-03-30 |
Compounds for the treatment of inflammatory disorders Grant 7,683,088 - Lavey , et al. March 23, 2 | 2010-03-23 |
Compounds for the treatment of inflammatory disorders Grant 7,652,020 - Guo , et al. January 26, 2 | 2010-01-26 |
Compounds For The Treatment Of Inflammatory Disorders App 20090170875 - Yu; Wensheng ;   et al. | 2009-07-02 |
Compounds For The Treatment Of Inflammatory Disorders App 20090156586 - Lavey; Brian J. ;   et al. | 2009-06-18 |
Compounds For The Treatment Of Inflammatory Disorders App 20090137586 - Yu; Wensheng ;   et al. | 2009-05-28 |
Compounds for the treatment of inflammatory disorders Grant 7,524,842 - Lavey , et al. April 28, 2 | 2009-04-28 |
Compounds for the treatment of inflammatory disorders Grant 7,504,424 - Yu , et al. March 17, 2 | 2009-03-17 |
Compounds for the treatment of inflammatory disorders Grant 7,488,745 - Yu , et al. February 10, 2 | 2009-02-10 |
Compounds for the treatment of inflammatory disorders App 20070265299 - Lavey; Brian J. ;   et al. | 2007-11-15 |
Compounds for the treatment of inflammatory disorders App 20070219218 - Yu; Wensheng ;   et al. | 2007-09-20 |
Compounds for the treatment of inflammatory disorders App 20070197564 - Lavey; Brian J. ;   et al. | 2007-08-23 |
Compounds for the treatment of inflammatory disorders App 20060276506 - Yu; Wensheng ;   et al. | 2006-12-07 |
Compounds for the treatment of inflammatory disorders App 20060252778 - Guo; Zhuyan ;   et al. | 2006-11-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.